| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |